Technical Analysis for MITO - Stealth BioTherapeutics Corp.

Grade Last Price % Change Price Change
grade F 11.0 -1.08% -0.12
MITO closed down 1.08 percent on Wednesday, July 17, 2019, on 32 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical MITO trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Doji - Bullish? Reversal 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Outside Day Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -1.08%
Lower Bollinger Band Walk Weakness -1.08%

Older signals for MITO ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate, Elamipretide, has the potential to treat rare genetic and common age-related mitochondrial diseases. The company's product candidates include SBT-20, a small peptide that targets and binds reversibly to cardiolipin, stabilizing mitochondrial structure, and function under conditions of oxidative stress; and SBT-272, a lead discovery pipeline compound, evaluating for rare neurodegenerative diseases, such as amyotrophic lateral sclerosis. Stealth BioTherapeutics Corp was founded in 2006 and is based in Newton, Massachusetts.
Biotechnology Biology Diseases Amyotrophic Lateral Sclerosis Peptides Degenerative Disease Senescence Neurodegeneration
Is MITO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 20.8
52 Week Low 11.0
Average Volume 5,695
200-Day Moving Average 0.0
50-Day Moving Average 12.7892
20-Day Moving Average 12.2961
10-Day Moving Average 11.951
Average True Range 0.5781
ADX 20.28
+DI 21.6157
-DI 36.9905
Chandelier Exit (Long, 3 ATRs ) 12.5657
Chandelier Exit (Short, 3 ATRs ) 12.7343
Upper Bollinger Band 13.5656
Lower Bollinger Band 11.0266
Percent B (%b) -0.01
BandWidth 20.648824
MACD Line -0.4018
MACD Signal Line -0.251
MACD Histogram -0.1508
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.75
Resistance 3 (R3) 11.83 11.67 11.63
Resistance 2 (R2) 11.67 11.48 11.63 11.58
Resistance 1 (R1) 11.33 11.36 11.25 11.25 11.54
Pivot Point 11.17 11.17 11.13 11.13 11.17
Support 1 (S1) 10.83 10.98 10.75 10.75 10.46
Support 2 (S2) 10.67 10.86 10.63 10.42
Support 3 (S3) 10.33 10.67 10.38
Support 4 (S4) 10.25